Spanish Registry of Cardioneuroablation (SRCNA)
Spanish multicenter registry of cardioneuroablation (ablation of cardiac ganglionated plexi) in patients with reflex syncope and functional bradyarrhythmias Background Cardioneuroablation (CNA) is the catheter ablation of the ganglionated plexi (GP) of the intrinsic cardiac autonomic nervous system, located in the atrial epicardial fat, to reduce parasympathetic tone on the sinus node and the atrioventricular (AV) node. It has been proposed as an alternative to pacemaker implantation in patients, often young, with cardioinhibitory reflex syncope or vagally mediated bradyarrhythmias. However, the available evidence comes mainly from single-center series at highly experienced centers, with heterogeneous techniques (choice of atrium, number of GP targeted, localization method, type of anesthesia) and no standardized acute procedural endpoint. Data from real-world clinical practice are needed to define its efficacy and safety, and to identify which patients and which procedural strategies are associated with better outcomes.
Objectives Primary: to assess syncope recurrence after CNA in real-world clinical practice in Spain.
Secondary: 1) to describe the procedural characteristics and complications of CNA; 2) to identify clinical and procedural predictors of success; 3) to evaluate the change in syncope and presyncope burden and the need for pacemaker implantation during follow-up.
Design Observational, multicenter, ambispective, ongoing registry with 27 participating hospitals in Spain. Cases performed since June 2018 are collected retrospectively, and prospective enrollment of consecutive patients has been in place since April 2021.
Study population
Inclusion criteria: consecutive patients undergoing CNA for syncope with one of the following phenotypes:
- Cardioinhibitory reflex syncope: bradycardia <40 bpm or asystole documented on tilt testing, Holter monitoring or implantable loop recorder.
- Mixed reflex syncope: blood pressure drop preceding the heart rate drop on tilt testing.
- Functional sinus node dysfunction.
- Functional AV block. Procedure
CNA is performed according to the usual practice of each center. The operator chooses:
- the approach (right atrium, left atrium or both);
- the number of GP targeted;
- the GP localization method (anatomical, fragmented electrograms, high-frequency stimulation, extracardiac vagal stimulation or combinations);
- the type of anesthesia (general anesthesia, deep sedation, conscious sedation). Data collected
- Baseline: demographics, body mass index, cardiovascular history and structural heart disease, type of syncope, number of syncopal and presyncopal episodes before CNA, and diagnostic tests (tilt testing, Holter, implantable loop recorder, atropine test).
- Procedural: approach, GP targeted, localization method, type of anesthesia, ablation catheter and navigation system, RF power and number of applications, procedure and fluoroscopy times, heart rate before and after CNA and response to atropine after the procedure.
- Safety: procedure-related complications, including sinus node dysfunction, inappropriate sinus tachycardia and vascular complications.
- Follow-up: syncope and presyncope recurrence, number of episodes per year, need for pacemaker implantation and other clinical events.
Endpoints Primary endpoint: first syncope recurrence after CNA. Secondary endpoints: procedure-related complications; number of syncopal and presyncopal episodes per year before and after CNA; pacemaker implantation during follow-up.
Ongoing sub-studies:
- long-term follow-up of these patients and identification of predictors of recurrence;
- redo procedures, in patients requiring more than one CNA;
- patients followed with an implantable loop recorder (subcutaneous Holter). Expected relevance This registry will provide multicenter real-world data on CNA in Spain. It will help to identify the patients most likely to benefit from the procedure and the technical aspects associated with success, and will generate hypotheses for future randomized trials.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Maria T Barrio-Lopez, MD PhD
- Phone Number: +34 655298270
- Email: terebarriol@gmail.com
Study Contact Backup
- Name: Jesus Almendral
- Email: almendraljesus@gmail.com
Study Locations
-
-
-
Albacete, Spain
- Recruiting
- Hospital Albacete
-
Alicante, Spain
- Recruiting
- Hospital General Alicante
-
Contact:
- Jose Luis Ibañez
- Email: ppluic77@gmail.com
-
Badajoz, Spain
- Recruiting
- Hospital Badajoz
-
Barcelona, Spain
- Recruiting
- Hospital Dexeus Barcelona
-
Contact:
- Ángel Moya
- Email: amoyamitjans@gmail.com
-
Barcelona, Spain
- Recruiting
- Hospital Vall d´Hebron
-
Bilbao, Spain
- Recruiting
- Hospital de Basurto
-
Contact:
- Jesus Martinez
- Email: txules@gmail.com
-
Córdoba, Spain
- Recruiting
- Hospital Reina Sofia
-
Girona, Spain
- Recruiting
- Hospital Josep Trueta
-
Granada, Spain
- Recruiting
- Hospital Virgen de las Nieves
-
Granada, Spain
- Recruiting
- Hospital Clinico Granada
-
Contact:
- Rosa Macias
- Email: rmacias148@msn.com
-
Huelva, Spain
- Recruiting
- Hospital Juan Ramón Jiménez
-
Madrid, Spain
- Recruiting
- Hospital Puerta de Hierro
-
Contact:
- Eusebio Garcia Izquierdo
- Email: usegij@gmail.com
-
Madrid, Spain
- Recruiting
- Hospital 12 de Octubre
-
Contact:
- Alvaro Marco, amarco89@hotmail.com
-
Madrid, Spain
- Recruiting
- Hospital Fundación Jiménez Díaz
-
Madrid, Spain
- Recruiting
- Hospital Gregorio Marañon
-
Madrid, Spain
- Recruiting
- Hospital Ramón y Cajal
-
Contact:
- Eduardo Franco
- Email: efranco@academiamir.com
-
Madrid, Spain
- Recruiting
- Hospital Torrejon
-
Contact:
- Teba González
- Email: tebagf@gmail.com
-
Navarro, Spain
- Recruiting
- Hospital Universitario de Navarra
-
Contact:
- Oscar Alcalde
- Email: 37053oar@gmail.com
-
Santander, Spain
- Recruiting
- Hospital Valdecilla
-
Santiago de Compostela, Spain
- Recruiting
- Hospital Santiago de Compostela
-
Contact:
- Carlos Minguito
- Email: carlosminguito@hotmail.es
-
Valencia, Spain
- Recruiting
- Hospital La Fe
-
Valladolid, Spain
- Recruiting
- Hospital Valladolid
-
Vigo, Spain
- Recruiting
- Hospital Álvaro Cunqueiro
-
Vitoria-Gasteiz, Spain
- Recruiting
- Hospital Txagorritxu
-
Zaragoza, Spain
- Recruiting
- Hospital Miguel Servet
-
-
Madrid
-
Madrid, Madrid, Spain, 28660
- Recruiting
- Hospital HM Monteprincipe
-
Contact:
- Teresa Barrio, MD PhD
- Phone Number: 655298270
- Email: terebarriol@gmail.com
-
Madrid, Madrid, Spain
- Recruiting
- Hospital La Paz
-
Contact:
- Carlos Alvarez
- Email: calvarezo@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
patients treated with cardioneuroablation
Description
Inclusion Criteria:
- patients treated with cardioneuroablation
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
syncope
Time Frame: From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)
|
recurrence of syncope |
From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications
Time Frame: During procedure and 3 months after
|
Complications |
During procedure and 3 months after
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SEC2021
- Spanish Society of Cardiology (Other Grant/Funding Number: Cardiac Rhythm society)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.